News

News

Breathroughs Recalled by National Cancer Act’s Anniversary

Dr. Michael Lieber is among several USC Norris Comprehensive Cancer Center researchers who have made important discoveries in the 40 years since the National Cancer Act was passed.

Read The Full Story

USC Researcher Probes Race/Ethnicity Roles in Obesity-Related Cancer Risk

Minorities with cancer may be more susceptible to complications of the disease, especially when obesity comes into play, according to research presented by a Keck School of Medicine professor at the American Association for Cancer Research (AACR) Annual Meeting 2012.

Read The Full Story

Novel Drug Target for Liver Cancer Identified

Researchers at the Keck School of Medicine of USC have identified a potential new drug target for hepatocellular carcinoma, the most common form of liver cancer in adults.

Read The Full Story

Rubicon Protein Key Regulator of Immune System, New Study Shows

A global team of microbiologists led by the Keck School of Medicine has identified a critical protein in the fight against bacterial and fungal infections like tuberculosis and ringworm, laying the groundwork for scientists to develop target-specific drugs that have fewer side effects.

Read The Full Story

Researchers Use Rat Stem Cells To Study Kaposi’s Sarcoma Virus

Keck School of Medicine of USC researchers have singled out the rat mesenchymal stem cell as an effective cell model to study the virus that causes Kaposi’s sarcoma, the most common cancer among AIDS patients.

Read The Full Story

Breathroughs Recalled by National Cancer Act’s Anniversary

Dr. Michael Lieber is among several USC Norris Comprehensive Cancer Center researchers who have made important discoveries in the 40 years since the National Cancer Act was passed.

Read The Full Story
University of Southern California University of Southern California